Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort

Helene Fontaine; Claire Fougerou-Leurent; Emmanuel Gordien; Caroline Scholtes; Sophie Metivier; Victor de Lédinghen; Vlad Ratziu; Laurent Alric; Nathalie Ganne-Carrié; Veronique Loustaud-Ratti; Dominique Guyader; Vincent Leroy; Jérôme Dumortier; Karine Lacombe; Georges-Philippe Pageaux; Anne Minello Franza; Christelle Tual; Alain Renault; Estelle Le Pabic; Lucie Marchand; Dominique Roulot; Fabien Zoulim

Journal Article

Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort

Fontaine H
Fougerou-Leurent C
Gordien E
et al.

Journal of Hepatology (2022) 77 S72

DOI: 10.1016/s0168-8278(22)00540-2

N/ACitations

5Readers

Get full text

Cite

CITATION STYLE

APA

Fontaine, H., Fougerou-Leurent, C., Gordien, E., Scholtes, C., Metivier, S., de Lédinghen, V., … Zoulim, F. (2022). Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort. Journal of Hepatology, 77, S72. https://doi.org/10.1016/s0168-8278(22)00540-2

Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort

Cite

Register to see more suggestions